Articles published by Cofactor Genomics

Cofactor Genomics Advances Predictive Cancer Diagnostics With Landmark OncoPrism-NSCLC Study

December 17, 2025

From Cofactor Genomics

Via Business Wire

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks

December 15, 2025

From Cofactor Genomics

Via Business Wire

Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision Medicine to Immunotherapy at RNA Society’s 30th Annual Meeting

May 30, 2025

From Cofactor Genomics

Via Business Wire

Cofactor Genomics Announces the Expansion of OncoPrism into Colorectal, Breast, Bladder, and Kidney Cancer

March 05, 2025

From Cofactor Genomics

Via Business Wire

Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients

November 17, 2023

From Cofactor Genomics

Via Business Wire

Stanford University Joins Cofactor Genomics’ Clinical Trial Evaluating Immunotherapy Predictive Diagnostic Assay Across 11 Cancers

July 11, 2023

From Cofactor Genomics

Via Business Wire

Culmination Bio and Cofactor Genomics Leverage Largest Biobank in the U.S. for PREDAPT Precision Medicine Clinical Trial

May 09, 2023

From Cofactor Genomics

Via Business Wire

Cofactor Genomics Opens Enrollment for Non-small Cell Lung Cancer Study of OncoPrism Predictive Diagnostic Assay

December 14, 2022

From Cofactor Genomics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.